Atypical chronic myeloid leukemia with der(20)t(17;20)(q21;q13)

Cancer Genetics and Cytogenetics

Volumn 112, Issue 2, 1999, Pages 130-133

  Ma, S K ^a   Wan, T S K ^a   Au, W Y ^a   Kwong, Y L ^a   Chan, L C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; MALE; PRIORITY JOURNAL;

EID: 0033030636     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00265-9     Document Type: Article

References (23)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H., Sultan C., Cox C. The chronic myeloid leukaemias. guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group Br J Haematol. 87:1994;746-754.
2. Costello R., Sainty D., Lafage-Pochitaloff M., Gabert J. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia. Leuk Lymphoma. 25:1997;225-232.
3. + CML and chronic myelomonocytic leukemia Blood. 78:1991;205-211.
4. Kurzrock R., Kantarjian H.M., Shtalrid M., Gutterman J.U., Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement. a chronic myeloid leukemia with a distinct clinical course Blood. 75:1990;445-452.
5. Selleri L., Emilia G., Luppi M., Temperani P., Zucchini P., Tagliafico E., Artusi T., Sarti M., Donelli A., Castoldi G.L., Ferrari S., Torelli U., Torelli G. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative." Hematol Pathol. 42:1990;67-77.
6. Oscier D.G. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? Br J Haematol. 92:1996;582-586.
7. Neuwirtová R., Mociková K., Musilová J., Jelínek J., Havlícek F., Michalová K., Adamkov M. Mixed myelodysplastic and myeloproliferative syndromes. Leukemia Res. 20:1996;717-726.
8. Dobrovic A., Morley A.A., Seshadri R., Januszewicz E.H. Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis. clinical features and course of M-bcr negative and M-bcr positive CML Leukemia. 5:1991;187-190.
9. Wiedemann L., Karhi K.K., Shivji M.K.K., Rayter S.I., Pegram S.M., Dowden G., Bevan D., Will A., Galton D.A.G., Chan L.C. The correlation of breakpoint cluster region rearrangement and p210 ph1/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood. 71:1988;349-355.
10. Ma S.K., Au K.L., Wan T.S.K., Chan L.C. Translocation (2;8)(q12;q24) in blastic transformation of atypical chronic myeloid leukemia. Leukemia. 11:1997;612-613.
11. Kantarjian H.M., Shtalrid M., Kurzrock R., Blick M., Dalton W.T., LeMaistre A., Stass S.A., McCredie K.B., Gutterman J., Freireich E.J., Talpaz M. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogeneous leukemia and chronic myelomonocytic leukemia. Am J Med. 85:1988;639-644.
12. Morris C.M., Reeve A.E., Fitzgerald P.H., Hillings P.E., Beard M.E.J., Heaton D.C. Genomic diversity correlates with clinical variation in Ph-negative chronic myeloid leukaemia. Nature. 320:1986;281-283.
13. Costello R., Lafage M., Toiron Y., Brunel V., Sainty D., Arnoulet C., Mozziconacci M.-J., Bouabdallab R., Gastaut J.-A., Maraninchi D., Gabert J. Philadelphia chromosome-negative myeloid leukaemia. a report of 14 cases Br J Haematol. 90:1995;346-352.
14. van der Plas D.C., Hermans A.B.C., Soekarman D., Smit E.M.E., de Klein A., Smadja N., Alimena G., Goudsmit R., Grosveld G., Hagemeijer A. Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 73:1989;1038-1044.
15. Chan L.C., Kwong Y.L., Liu H.W., Chan T.K., Todd D., Ching L.M. Cytogenetic analysis of hematologic malignancies in Hong Kong - a study of 98 cases. Cancer Genet Cytogenet. 62:1992;154-159.
16. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
17. Kwong Y.L., Chiu E.K.W., Liang R.H.S., Chan V., Chan T.K. Essential thrombocythemia with BCR/ABL rearrangement. Cancer Genet Cytogenet. 89:1996;74-76.
18. Chan L.C., Ha S.Y., Ching L.M., Lee C.P., Lau Y.L., Yuen P., Leung N.K. Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemia in Hong Kong. Cancer Genet Cytogenet. 76:1994;118-124.
19. Bettelheim P., Lutz D., Majdic O., Paietta E., Haas O., Linkesch W., Neumann E., Lechner K., Knapp W. Cell lineage heterogeneity in blastic crisis of chronic myeloid leukaemia. Br J Haematol. 59:1985;395-409.
20. Mertens F., Johansson B., Heim S., Kristoffersson U., Mandahl N., Truesson I., Malm C., Othzén A., Bartram C.R., Catovsky D., Mitelman F. Trisomy 14 in atypical chronic myeloid leukemia. Leukemia. 4:1990;117-120.
21. Mancini M., Cedrone M., Nanni M., Rondinelli M.B., Petti M.C., De Cuia M.R., Alimena G. Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disorders. Cancer Genet Cytogenet. 66:1993;39-42.
22. Toze C.L., Barnett M.J., Naiman S.C., Horsman D.E. Trisomy 14 is a non-random karyotypic abnormality associated with myeloid malignancies. Br J Haematol. 98:1977;177-185.
23. Asimakopoulos F.A., Green A.R. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol. 95:1996;219-226.